https://www.selleckchem.com/pr....oducts/bso-l-buthion
The main analysis will be a modified intention-to-treat analysis. This will include all randomised women (with a viable pregnancy) using EMA and follow-up for the main outcome. The study initiated on 13 January 2020 and is anticipated to finish in late 2021. Ethical approval was given by the South East Scotland NHS Research Ethics Committee, reference 19/SS/0111. Results will be published in peer-reviewed journals, presented at clinical and academic meetings, and shared with participants via the clinic website.
Like
Comment
Share
